Benefits of PresVu Eye Drops for Presbyopia Treatment

Entod Pharmaceuticals' "PresVu" eye drops have been approved by the Drugs Controller General of India (DCGI) as a breakthrough treatment for presbyopia.

[{"selector":"#anim-aed93e37-4de0-48c2-85ba-c417920edfbc","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-3dfaaa3b-8f4d-44e8-adb4-680b238a50a6","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Presbyopia is an age-related condition that affects near vision, typically occurring in people over the age of 40.

[{"selector":"#anim-542605b7-e07f-40e1-822f-6147d1364160","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-4de02682-d44b-4ab1-9201-588b22f603f8","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The Subject Expert Committee of the Central Drugs Standard Control Organization (CDSCO) has also approved PresVu for use.

[{"selector":"#anim-4bd3e17e-7936-401e-9dac-8588e472c6ee","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-7f97aaf9-cbf4-4c00-ba0f-accb95998aec","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

PresVu is the first eye drop in India specifically designed to treat presbyopia, providing an alternative to reading glasses.

[{"selector":"#anim-fecd866f-42f9-4e04-a630-260ad4191dd9","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-6f77a418-50aa-48e4-95ec-2607d82fd540","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

It is estimated that 1.09 to 1.80 billion people worldwide suffer from presbyopia, highlighting its widespread impact.

[{"selector":"#anim-02e7497b-46e4-4c50-8e86-977e72786580","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-ba623a42-bacb-4512-98a8-b83ba69559e4","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Entod Pharmaceuticals developed PresVu after years of research and development, aiming to revolutionize eye care in India.

[{"selector":"#anim-a0d18f49-5b8d-4ed8-8993-2f162583d7a4","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-733c3d9d-5048-4d88-8064-c45e8a216ff1","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The company has applied for a patent for PresVu's unique formulation and process.

[{"selector":"#anim-20fa0fa7-5786-42d0-b310-8c8e37b2209e","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-8940e01c-12ff-49c6-b7b0-b5dcf17ad17d","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

PresVu not only improves near vision but also lubricates the eyes, providing extra comfort for patients.

[{"selector":"#anim-4c339cea-6577-4644-8e8b-e049a2aeb215","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-85046922-ea25-42c3-b722-db7b6a25f891","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The formula uses dynamic buffer technology, allowing it to adapt to the pH of tears and remain effective for a longer period.

[{"selector":"#anim-9c64dd0c-fd7a-4da0-b7cc-63c1c7c2ea91","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-eb21412c-586d-46d9-b2b4-edf54d7e2514","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

PresVu enhances near vision within 15 minutes of application, providing quick relief for patients.

[{"selector":"#anim-7d942ea8-cd62-4367-b255-0db96a1ff888","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-9d79c88f-74c7-47dd-9955-e96d7ec68aab","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

The eye drops can significantly enhance the quality of life by enabling people to perform daily tasks more easily.

[{"selector":"#anim-1da1a739-0cb5-4b88-8a8c-0a8acf702dc2","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-1716dc05-ae5b-4b81-9aeb-340ce49869fd","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Ophthalmologists like Dr. Tatyarao Rhane praised PresVu for its clinical potential in improving vision without the need for reading glasses.

[{"selector":"#anim-c6f00b3c-949a-4984-964d-54d2df4ef82e","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-1962abc1-dc33-4f0e-a66b-50908fd459c5","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}]

Follow the English With Arsod Sir channel on WhatsApp:

[{"selector":"#anim-58f40062-4af4-41ff-a8bd-6259e8465cae","keyframes":[{"offset":0,"transform":"translate3d(0, -221.35321%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.29,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.45,"transform":"translate3d(0, -62.244522652%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.61,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.71,"transform":"translate3d(0, -21.161366876%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.8,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.85,"transform":"translate3d(0, -7.946580239%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.92,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.96,"transform":"translate3d(0, -3.4531100759999998%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":1,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"}],"delay":0,"duration":600,"fill":"both"}] Thanks for Reading. Read More Stories